Understanding PRRSV infection in porcine lung based on genome-wide transcriptome response identified by deep sequencing.

Shuqi Xiao, Jianyu Jia, Delin Mo, Qiwei Wang, Limei Qin, Zuyong He, Xiao Zhao, Yuankai Huang, Anning Li, Jingwei Yu, Yuna Niu, Xiaohong Liu, Yaosheng Chen
Author Information
  1. Shuqi Xiao: State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China.

Abstract

Porcine reproductive and respiratory syndrome (PRRS) has been one of the most economically important diseases affecting swine industry worldwide and causes great economic losses each year. PRRS virus (PRRSV) replicates mainly in porcine alveolar macrophages (PAMs) and dendritic cells (DCs) and develops persistent infections, antibody-dependent enhancement (ADE), interstitial pneumonia and immunosuppression. But the molecular mechanisms of PRRSV infection still are poorly understood. Here we report on the first genome-wide host transcriptional responses to classical North American type PRRSV (N-PRRSV) strain CH 1a infection using Solexa/Illumina's digital gene expression (DGE) system, a tag-based high-throughput transcriptome sequencing method, and analyse systematically the relationship between pulmonary gene expression profiles after N-PRRSV infection and infection pathology. Our results suggest that N-PRRSV appeared to utilize multiple strategies for its replication and spread in infected pigs, including subverting host innate immune response, inducing an anti-apoptotic and anti-inflammatory state as well as developing ADE. Upregulation expression of virus-induced pro-inflammatory cytokines, chemokines, adhesion molecules and inflammatory enzymes and inflammatory cells, antibodies, complement activation were likely to result in the development of inflammatory responses during N-PRRSV infection processes. N-PRRSV-induced immunosuppression might be mediated by apoptosis of infected cells, which caused depletion of immune cells and induced an anti-inflammatory cytokine response in which they were unable to eradicate the primary infection. Our systems analysis will benefit for better understanding the molecular pathogenesis of N-PRRSV infection, developing novel antiviral therapies and identifying genetic components for swine resistance/susceptibility to PRRS.

References

  1. Virology. 1999 Sep 15;262(1):152-62 [PMID: 10489349]
  2. Nature. 2009 Nov 26;462(7272):510-3 [PMID: 19898495]
  3. Pharmacogenomics. 2005 Jun;6(4):373-82 [PMID: 16004555]
  4. Microbes Infect. 2007 Jan;9(1):96-102 [PMID: 17194611]
  5. Nat Rev Immunol. 2006 Nov;6(11):813-22 [PMID: 17039247]
  6. Transbound Emerg Dis. 2008 May;55(3-4):152-64 [PMID: 18405338]
  7. Nat Rev Immunol. 2008 Jul;8(7):559-68 [PMID: 18575461]
  8. Hepatology. 2008 Mar;47(3):799-809 [PMID: 18203148]
  9. J Virol. 2007 Jul;81(14):7371-9 [PMID: 17494075]
  10. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2448-53 [PMID: 8637894]
  11. Curr Opin Immunol. 2006 Aug;18(4):422-9 [PMID: 16782318]
  12. Infect Immun. 2006 Oct;74(10):5561-73 [PMID: 16988231]
  13. Viral Immunol. 2007 Spring;20(1):105-18 [PMID: 17425425]
  14. J Virol. 2004 Sep;78(17):9499-511 [PMID: 15308742]
  15. Clin Diagn Lab Immunol. 2004 Sep;11(5):901-8 [PMID: 15358650]
  16. Vet J. 2008 Sep;177(3):345-51 [PMID: 17644436]
  17. Nat Rev Genet. 2010 Jan;11(1):9-16 [PMID: 19935729]
  18. Int J Biol Sci. 2007 Feb 10;3(3):179-84 [PMID: 17384736]
  19. Arch Virol. 1997;142(3):629-33 [PMID: 9349308]
  20. Clin Vaccine Immunol. 2008 Apr;15(4):720-5 [PMID: 18272667]
  21. Virus Res. 2009 Mar;140(1-2):161-71 [PMID: 19111584]
  22. Genome Res. 2008 Jun;18(6):957-64 [PMID: 18469162]
  23. Nat Rev Immunol. 2009 Sep;9(9):645-55 [PMID: 19696766]
  24. Vaccine. 2009 Jun 8;27(28):3704-18 [PMID: 19464553]
  25. Vet Res. 2000 Jan-Feb;31(1):27-39 [PMID: 10726636]
  26. Emerg Infect Dis. 2003 Sep;9(9):1064-9 [PMID: 14519241]
  27. Nat Rev Genet. 2010 Jan;11(1):31-46 [PMID: 19997069]
  28. J Gen Virol. 2006 Aug;87(Pt 8):2341-2351 [PMID: 16847130]
  29. Adv Exp Med Biol. 1998;440:461-7 [PMID: 9782316]
  30. PLoS One. 2007 Jun 13;2(6):e526 [PMID: 17565379]
  31. Cell Res. 2010 Jan;20(1):1-3 [PMID: 20046199]
  32. J Virol. 2007 Jan;81(2):514-24 [PMID: 17079289]
  33. Vet J. 2007 Nov;174(3):577-84 [PMID: 17869553]
  34. Virus Res. 2008 Apr;133(1):101-12 [PMID: 17451827]
  35. Biofactors. 2009 Jan-Feb;35(1):14-20 [PMID: 19319841]
  36. Nat Rev Immunol. 2007 Jan;7(1):31-40 [PMID: 17186029]
  37. J Gen Virol. 2003 Feb;84(Pt 2):453-459 [PMID: 12560579]
  38. Nat Rev Immunol. 2005 Apr;5(4):318-30 [PMID: 15803151]
  39. Virology. 2010 Jan 5;396(1):30-6 [PMID: 19897220]
  40. Nat Genet. 2000 May;25(1):25-9 [PMID: 10802651]
  41. J Virol Methods. 2009 Nov;161(2):192-8 [PMID: 19539654]
  42. J Immunol. 2000 Sep 1;165(5):2327-30 [PMID: 10946253]
  43. Nat Immunol. 2010 Jan;11(1):63-9 [PMID: 19915568]
  44. J Am Vet Med Assoc. 2005 Aug 1;227(3):385-92 [PMID: 16121604]
  45. Nat Rev Genet. 2010 Jan;11(1):75-87 [PMID: 20019688]
  46. J Immunol. 2004 Jun 15;172(12):7841-7 [PMID: 15187168]
  47. Dev Biol (Basel). 2008;132:169-174 [PMID: 18817299]
  48. Nat Rev Immunol. 2006 Mar;6(3):183-95 [PMID: 16498449]
  49. Transbound Emerg Dis. 2009 May;56(4):121-31 [PMID: 19245667]
  50. Cell Res. 2010 Jan;20(1):34-50 [PMID: 20010915]
  51. J Interferon Cytokine Res. 1998 Jul;18(7):485-90 [PMID: 9712364]
  52. J Gen Virol. 2008 Dec;89(Pt 12):2943-2953 [PMID: 19008379]
  53. Nat Biotechnol. 2007 Aug;25(8):878-80 [PMID: 17687366]
  54. Hum Gene Ther. 2001 Jul 1;12(10):1343-52 [PMID: 11440627]
  55. Sci China C Life Sci. 2008 Mar;51(3):271-9 [PMID: 18246315]
  56. Cancer Cell. 2002 Nov;2(5):353-61 [PMID: 12450790]
  57. Res Vet Sci. 1999 Aug;67(1):47-52 [PMID: 10425240]
  58. Nat Rev Immunol. 2005 Dec;5(12):917-27 [PMID: 16322745]
  59. Vet Microbiol. 1997 Apr;55(1-4):309-16 [PMID: 9220627]
  60. J Interferon Cytokine Res. 2007 Sep;27(9):757-66 [PMID: 17892397]
  61. J Cell Biochem. 2004 Apr 15;91(6):1099-108 [PMID: 15048867]
  62. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9121-6 [PMID: 12082179]
  63. Genome Res. 1997 Oct;7(10):986-95 [PMID: 9331369]
  64. J Virol. 2007 Nov;81(22):12169-78 [PMID: 17855515]
  65. J Gen Virol. 2003 Oct;84(Pt 10):2755-2760 [PMID: 13679610]
  66. Arch Virol. 2008;153(8):1453-65 [PMID: 18563285]
  67. J Virol. 2006 Mar;80(6):3009-20 [PMID: 16501110]
  68. Vet Microbiol. 2003 Dec 2;97(1-2):1-12 [PMID: 14637034]
  69. Trends Endocrinol Metab. 2010 Jan;21(1):33-40 [PMID: 19854061]
  70. Nat Rev Immunol. 2010 Jan;10(1):24-35 [PMID: 20029446]
  71. Mamm Genome. 2005 Oct;16(10):792-800 [PMID: 16261421]
  72. Arch Virol. 2007 Feb;152(2):289-303 [PMID: 17031757]
  73. J Endotoxin Res. 2004;10(4):201-22 [PMID: 15373964]
  74. J Virol. 2010 Feb;84(3):1574-84 [PMID: 19923190]
  75. Nature. 2007 Jan 18;445(7125):319-23 [PMID: 17230189]
  76. Immunology. 2007 Feb;120(2):217-29 [PMID: 17116172]
  77. Nat Rev Immunol. 2004 Mar;4(3):223-31 [PMID: 15039759]
  78. Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):309-19 [PMID: 15963827]
  79. Science. 1998 Aug 28;281(5381):1309-12 [PMID: 9721092]
  80. J Gen Virol. 2008 Oct;89(Pt 10):2550-2564 [PMID: 18796724]
  81. J Exp Med. 2005 May 2;201(9):1355-9 [PMID: 15867089]
  82. J Gen Virol. 2001 Jun;82(Pt 6):1253-1261 [PMID: 11369868]
  83. Mol Immunol. 2009 Sep;46(15):2918-30 [PMID: 19631987]
  84. Cell Host Microbe. 2008 Sep 11;4(3):198-208 [PMID: 18779046]
  85. Nat Rev Immunol. 2008 Aug;8(8):644-54 [PMID: 18654572]
  86. Nat Rev Immunol. 2006 Dec;6(12):940-52 [PMID: 17124515]
  87. Nat Rev Immunol. 2008 Dec;8(12):911-22 [PMID: 18989317]
  88. Virology. 2007 Sep 1;365(2):419-34 [PMID: 17488647]

MeSH Term

Animals
Base Sequence
DNA Primers
Gene Expression Profiling
Genes, Viral
Polymerase Chain Reaction
Porcine Reproductive and Respiratory Syndrome
Porcine respiratory and reproductive syndrome virus
Quantitative Trait Loci
Swine

Chemicals

DNA Primers

Word Cloud

Created with Highcharts 10.0.0infectionN-PRRSVPRRSVcellsPRRSexpressionresponseinflammatoryswineporcineADEimmunosuppressionmoleculargenome-widehostresponsesgenetranscriptomesequencinginfectedimmuneanti-inflammatorydevelopingPorcinereproductiverespiratorysyndromeoneeconomicallyimportantdiseasesaffectingindustryworldwidecausesgreateconomiclossesyearvirusreplicatesmainlyalveolarmacrophagesPAMsdendriticDCsdevelopspersistentinfectionsantibody-dependentenhancementinterstitialpneumoniamechanismsstillpoorlyunderstoodreportfirsttranscriptionalclassicalNorthAmericantypestrainCH1ausingSolexa/Illumina'sdigitalDGEsystemtag-basedhigh-throughputmethodanalysesystematicallyrelationshippulmonaryprofilespathologyresultssuggestappearedutilizemultiplestrategiesreplicationspreadpigsincludingsubvertinginnateinducinganti-apoptoticstatewellUpregulationvirus-inducedpro-inflammatorycytokineschemokinesadhesionmoleculesenzymesantibodiescomplementactivationlikelyresultdevelopmentprocessesN-PRRSV-inducedmightmediatedapoptosiscauseddepletioninducedcytokineunableeradicateprimarysystemsanalysiswillbenefitbetterunderstandingpathogenesisnovelantiviraltherapiesidentifyinggeneticcomponentsresistance/susceptibilityUnderstandinglungbasedidentifieddeep

Similar Articles

Cited By